2019

Witlox WJA, van Asselt ADI, Wolff RArmstrong NWorthy GChalker ABuksnys TStirk LKleijnen J, Joore MA, Grimm SE. Durvalumab for the treatment of locally advanced, unresectable, stage III non‑small cell lung cancer: an Evidence Review Group perspective of a NICE single technology appraisal. Pharmacoeconomics 2019;Epub ahead of print. Full text.

 

van Tol RR, Kleijnen J, Watson AJM, Jongen J, Altomare DF, Qvist N, et al. European Society of ColoProctology (ESCP): guideline for haemorrhoidal disease [Internet]. Edinburgh: European Society of ColoProctology (ESCP), 2019 [accessed 4.12.19] Full text.

 

Timmermans YEG, van de Kant KDG, Oosterman EO, Spaanderman MEA, Villamor-Martinez E, Kleijnen J, et al. The impact of interpregnancy weight change on perinatal outcomes in women and their children: a systematic review and meta-analysis. Obes Rev 2019;Epub ahead of print. Full text.

 

Pouwels XGLV, Petersohn S, Huertas Carrera V, Denniston AK, Chalker ARaatz HArmstrong N, Shah D, Witlox W, Worthy GNoake CRiemsma RKleijnen J, Joore MA. Fluocinolone acetonide intravitreal implant for treating recurrent non-infectious uveitis: an Evidence Review Group perspective of a NICE single technology appraisal. Pharmacoeconomics 2019;Epub ahead of print. Full text.

 

Swift SLLang SH, White H, Misso KKleijnen J, Quek RG. Effect of DNA damage response mutations on prostate cancer prognosis: a systematic review. Future Oncol 2019;Epub ahead of print. Full text.

 

Kernen P, Steveling-Klein EH, Saccilotto RT, Raatz H, Briel M, Koller MT, Westwood M, Bucher HC, Miedinger D, Leuppi JD. The sensitivity and specificity of the mannitol bronchial challenge test to identify asthma in different populations: a systematic review. Swiss Med Wkly 2019;149:w20100. Full text.

 

Buksnys TArmstrong NWorthy G, Sabatschus I, Boesl I, Buchheister B, Swift SLNoake CHuertas Carrera VRyder S, Shah D, Liedgens H, Kleijnen J. Systematic review and network meta-analysis of the efficacy and safety of lidocaine 700 mg medicated plaster vs. pregabalin. Curr Med Res Opin 2019;Epub ahead of print. Full text.

 

Ubachs J, Ziemons J, Minis-Rutten IJG, Kruitwagen RFPM, Kleijnen J, Lambrechts S, et al. Sarcopenia and ovarian cancer survival: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle 2019;Epub ahead of print. Full text.

 

Glinz D, Gloy VL, Monsch AU, Kressig RW, Patel C, McCord KA, Ademi Z, Tomonaga Y, Schwenkglenks M, Bucher HC, Raatz H. Acetylcholinesterase inhibitors combined with memantine for moderate to severe Alzheimer's disease: a meta-analysis. Swiss Med Wkly 2019;149:w20093. Full text.

 

Lang SHSwift SL, White H, Misso KKleijnen J, Quek RGW. A systematic review of the prevalence of DNA damage response gene mutations in prostate cancer. Int J Oncol 2019;Epub ahead of print. Full text.

 

Lang SSwift SDuffy SKleijnen J. Taking account of tumour heterogeneity in systematic reviews. Paper presented at EBMLive 2019; 15-17 Jul 2019; Oxford. BMJ Evidence-Based Medicine 2019;24(Suppl 1):A44. Poster.

 

Armstrong NRyder SForbes CRoss J, Quek RGW. A systematic review of the international prevalence of BRCA mutation in breast cancer. Clin Epidemiol 2019;11:543-61. Full text.

 

van den Houten MML, Hageman D, Gommans LNM, Kleijnen J, Scheltinga MRM, Teijink JAW. The effect of supervised exercise, home based exercise and endovascular revascularisation on physical activity in patients with intermittent claudication: a network meta-analysis. Eur J Vasc Endovasc Surg 2019;[Epub ahead of print]. Abstract.

 

van Laake-Geelen CCM, Smeets RJEM, Quadflieg SPAB, Kleijnen J, Verbunt JA. The effect of exercise therapy combined with psychological therapy on physical activity and quality of life in patients with painful diabetic neuropathy: a systematic review. Scand J Pain 2019;[Epub ahead of print]. Abstract.

 

Ryder S, Fox K, Rane P, Armstrong N, Wei C-Y, Deshpande S, Stirk L, Qian Y, Kleijnen J. A systematic review of direct cardiovascular event costs: an international perspective. PharmacoEcon 2019;Epub ahead of print. Abstract.

 

Grimm SE, Fayter D, Ramaekers BLT, Petersohn S, Riemsma RArmstrong N, Pouwels X, Witlox W, Noake CWorthy GKleijnen J, Joore MA. Pembrolizumab for treating relapsed or refractory classical Hodgkin lymphoma: an Evidence Review Group perspective of a NICE single technology appraisal. Pharmacoeconomics 2019;Epub ahead of print. Full text.

 

Forbes CFayter Dde Kock S, Quek RGW. A systematic review of international guidelines and recommendations for the genetic screening, diagnosis, genetic counseling, and treatment of BRCA-mutated breast cancer. Cancer Manag Res 2019;11:2321-37Full text.

 

Majoie HJM, van Gaalen J, Verstegen DML, van Mastrigt GAPG, Kleijnen J, Alonso-Coello P, et al. Cost-conscious high-quality care and guideline development education: a strange contradiction or simple solution? Letter. Eur J Neurol 2019;26(4):e48-e49.

 

Hillemanns P, Friese K, Dannecker C, Klug S, Seifert U, Iftner T, Hädicke J, Löning T, Horn L, Schmidt D, Ikenberg H, Steiner M, Freitag U, Siebert U, Sroczynski G, Sauerbrei W, Beckmann MW, Gebhardt M, Friedrich M, Münstedt K, Schneider A, Kaufmann A, Petry KU, Schäfer APA, Pawlita M, Weis J, Mehnert A, Fehr M, Grimm C, Reich O, Arbyn M, Kleijnen J, Wesselmann S, Nothacker M, Follmann M, Langer T, Jentschke M. Prevention of cervical cancer: guideline of the DGGG and the DKG (S3 Level, AWMF register number 015/027OL, December 2017) - Part 1 with introduction, screening and the pathology of cervical dysplasia. Geburtshilfe Frauenheilkd 2019;79(2):148-59. Full text.

 

Hillemanns P, Friese K, Dannecker C, Klug S, Seifert U, Iftner T, Hädicke J, Löning T, Horn L, Schmidt D, Ikenberg H, Steiner M, Freitag U, Siebert U, Sroczynski G, Sauerbrei W, Beckmann MW, Gebhardt M, Friedrich M, Münstedt K, Schneider A, Kaufmann A, Petry KU, Schäfer APA, Pawlita M, Weis J, Mehnert A, Fehr M, Grimm C, Reich O, Arbyn M, Kleijnen J, Wesselmann S, Nothacker M, Follmann M, Langer T, Jentschke M. Prevention of cervical cancer: guideline of the DGGG and the DKG (S3 Level, AWMF register number 015/027OL, December 2017) - Part 2 on triage, treatment and follow-up. Geburtshilfe Frauenheilkd 2019;79(2):160-76. Full text.

 

Wolff RF, Moons KGM, Riley RD, Whiting PF, Westwood M, Collins GS, Reitsma JB, Kleijnen J, Mallett S, PROBAST Group. PROBAST: a tool to assess the risk of bias and applicability of prediction model studies. Ann Intern Med 2019;170(1):51-58. Full text.

 

Moons KGM, Wolff RF, Riley RD, Whiting PF, Westwood M, Collins GS, Reitsma JB, Kleijnen J, Mallett S. PROBAST: a tool to assess the risk of bias and applicability of prediction model studies: explanation and elaboration. Ann Intern Med 2019;170(1):W1-W33. Full text.